
Alina Markova MD
Associate Attending, Clinical Director of Dermatology Service
Request appointment
530 East 74th StreetNew York, NY 10021
Overview of Dr. Markova
Dr. Alina Markova is a dermatologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from The Warren Alpert Medical School of Brown University and has been in practice 14 years. She is one of 51 doctors at Memorial Sloan Kettering Cancer Center who specialize in Dermatology. She has more than 80 publications and over 500 citings.
Education & Training
Boston University Medical CenterResidency, Dermatology, 2013 - 2016
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2012 - 2013
The Warren Alpert Medical School of Brown UniversityClass of 2012, MD
Johns Hopkins UniversityBA, Mathematics, 2004 - 2008
Certifications & Licensure
FL State Medical License 2021 - Present
CT State Medical License 2025 - 2027
NJ State Medical License 2022 - 2027
NY State Medical License 2016 - 2027
MA State Medical License 2012 - 2016
American Board of Dermatology Dermatology
Clinical Trials
- Study of the Safety and Efficacy of Ruxolitinib Cream for Non-Sclerotic Chronic Cutaneous Graft-Versus-Host Disease Start of enrollment: 2019 May 14
- Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies Start of enrollment: 2020 Sep 16
- A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer Start of enrollment: 2021 Dec 15
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Benralizumab for Eosinophil-Related Cutaneous Adverse Events of Anticancer Therapy: A Phase II Trial.Mario E Lacouture, Alexander Pan, Tara Maier, Anna Chen, George Dranitsaris
Clinical Cancer Research. 2026-08-03 - Prevalence, incidence, and risk factors of secondary malignancies in patients with polycythemia vera: a real-world study.Naveen Pemmaraju, Alina Markova, Lucia Masarova, Nancy Reaven, Susan Funk
Blood Advances. 2026-07-14 - Safety of dermatologic surgery during immune checkpoint inhibitor therapy.Michael J Davis, Megan Trager, Yassaman Erfani, Stephen Dusza, Alina Markova
Journal of the American Academy of Dermatology. 2026-07-01
Press Mentions
Q&A with Director of the NIH Dermatology Consultation ServiceDecember 24th, 2024
Are Nail Salon UV Lamps a Skin Cancer Risk?April 30th, 2014
Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast CancerFebruary 13th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









